120 related articles for article (PubMed ID: 11073152)
21. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
22. Increased prevalence of oral Candida albicans serotype B in homosexual men: a comparative and longitudinal study in HIV-infected and HIV-negative patients.
Torssander J; Chryssanthou E; Petrini B
Mycoses; 1996; 39(9-10):353-6. PubMed ID: 9009657
[TBL] [Abstract][Full Text] [Related]
23. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects.
De Bernardis F; Boccanera M; Rainaldi L; Guerra CE; Quinti I; Cassone A
Eur J Epidemiol; 1992 May; 8(3):362-7. PubMed ID: 1356827
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
Ruhnke M; Tennagen I; Engelmann E
Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
[TBL] [Abstract][Full Text] [Related]
25. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
Sangeorzan JA; Bradley SF; He X; Zarins LT; Ridenour GL; Tiballi RN; Kauffman CA
Am J Med; 1994 Oct; 97(4):339-46. PubMed ID: 7942935
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous carriage of Candida albicans strains from HIV-infected patients with oral candidiasis: multilocus enzyme electrophoresis analysis.
Reynes J; Pujol C; Moreau C; Mallié M; Renaud F; Janbon F; Bastide JM
FEMS Microbiol Lett; 1996 Apr; 137(2-3):269-73. PubMed ID: 8998997
[TBL] [Abstract][Full Text] [Related]
28. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5.
Nikawa H; Jin C; Makihira S; Hamada T; Samaranayake LP
J Prosthet Dent; 2002 Sep; 88(3):263-7. PubMed ID: 12426495
[TBL] [Abstract][Full Text] [Related]
30. Biotypes of oral Candida albicans isolates in human immunodeficiency virus-infected patients from diverse geographic locations.
Tsang PC; Samaranayake LP; Philipsen HP; McCulloug M; Reichart PA; Schmidt-Westhausen A; Scully C; Porter SR
J Oral Pathol Med; 1995 Jan; 24(1):32-6. PubMed ID: 7722918
[TBL] [Abstract][Full Text] [Related]
31. [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].
Castillo-Martínez NA; Mouriño-Pérez RR; Cornejo-Bravo JM; Gaitán-Cepeda LA
Rev Chilena Infectol; 2018 Aug; 35(4):377-385. PubMed ID: 30534924
[TBL] [Abstract][Full Text] [Related]
32. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic diversity of oral C. albicans isolated on single and sequential visits in an HIV-infected Chinese cohort.
Samaranayake YH; Samaranayake LP; Yau JY; Dassanayake RS; Li TK; Anil S
APMIS; 2003 Feb; 111(2):329-37. PubMed ID: 12716390
[TBL] [Abstract][Full Text] [Related]
34. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients.
Campo J; Del Romero J; Castilla J; García S; Rodríguez C; Bascones A
J Oral Pathol Med; 2002 Jan; 31(1):5-10. PubMed ID: 11896816
[TBL] [Abstract][Full Text] [Related]
35. Carriage of Candida species in oral cavities of HIV infected patients in South India.
Girish Kumar CP; Menon T; Rajasekaran S; Sekar B; Prabu D
Mycoses; 2009 Jan; 52(1):44-8. PubMed ID: 18522700
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand.
Teanpaisan R; Nittayananta W
J Oral Pathol Med; 1998 Jan; 27(1):4-7. PubMed ID: 9466727
[TBL] [Abstract][Full Text] [Related]
37. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis.
Arribas JR; Hernández-Albujar S; González-García JJ; Peña JM; Gonzalez A; Cañedo T; Madero R; Vazquez JJ; Powderly WG
AIDS; 2000 May; 14(8):979-85. PubMed ID: 10853979
[TBL] [Abstract][Full Text] [Related]
38. [Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
Pathol Biol (Paris); 1994 Jun; 42(6):567-73. PubMed ID: 7854856
[TBL] [Abstract][Full Text] [Related]
39. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
40. Application of RAPD and restriction enzyme analysis to the study of oral carriage of Candida albicans.
Howell SA; Anthony RM; Power E
Lett Appl Microbiol; 1996 Feb; 22(2):125-8. PubMed ID: 8936372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
